secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2022-01-13T23:59:59+00:00
Accession:  0001564590-22-001203
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon exchanges 550K common for Series X1 preferred; convertible at 55.56 per share
--------------------------------------------------------------------------------

- Exchanged 550,000 common shares for 9,899.99 Series X1 preferred shares with BVF entities.
- Series X1 preferred convertible into ~6.55M shares at 55.5556 common per preferred (post-reverse split).
- After exchange, common outstanding: 13,756,788; Series X1 preferred outstanding: ~117,970 shares.
- Exchange exempt under Section 3(a)(9) of Securities Act; no registration required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000156459022001203/0001564590-22-001203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000156459022001203/eldn-8k_20220111.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-001203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer